This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Author: Avi Kapoor | July 21, 2025 08:24am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
JP Morgan analyst Drew Chamberlain initiated coverage on Argan, Inc. (NYSE:AGX) with a Neutral rating and announced a price target of $220. Argan shares closed at $206.63 on Friday. See how other analysts view this stock.
RBC Capital analyst Mike Dahl initiated coverage on QXO, Inc. (NYSE:QXO) with an Outperform rating and announced a price target of $33. QXO shares closed at $21.63 on Friday. See how other analysts view this stock.
Barclays initiated coverage on Albertsons Companies, Inc. (NYSE:ACI) with an Underweight rating and announced a price target of $19. Albertsons shares closed at $20.47 on Friday. See how other analysts view this stock.
Loop Capital analyst Mark Schappel initiated coverage on Autodesk, Inc. (NASDAQ:ADSK) with a Hold rating and announced a price target of $320. Autodesk shares closed at $297.03 on Friday. See how other analysts view this stock.
Truist Securities analyst Danielle Brill initiated coverage on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) with a Buy rating and announced a price target of $385. Alnylam Pharmaceuticals shares closed at $320.53 on Friday. See how other analysts view this stock.
Considering buying ALNY stock? Here’s what analysts think:
